REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC NSCLC AFTER RECEIVING FIRST-LINE PEMBROLIZUMAB WITH PEMETREXED/PLATINUM CHEMOTHERAPY IN THE US ONCOLOGY NETWORK

被引：0
|
作者：
Goldschmidt, Jerome [1 ]
Annavarapu, Srinivas [2 ]
Venkatasetty, Divea [2 ]
Santorelli, Melissa [3 ]
Burke, Thomas [3 ]
Pennell, Nathan [4 ]
机构：
[1] US Oncol Network, Blacksburg, VA USA
[2] Ontada, Irving, TX USA
[3] Merck & Co Inc, Rahway, NJ 07065 USA
[4] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0933
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
933
引用
收藏
页码：A974 / A975
页数：2
相关论文
共 50 条
  • [21] Real-World First-Line Treatment Patterns Among US Carcinoid Syndrome Patients
    Sun, Gordon H.
    Neary, Maureen P.
    Chang, Eunice
    Broder, Michael S.
    [J]. PANCREAS, 2015, 44 (02) : 359 - 360
  • [22] Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
    Leonetti, Alessandro
    Perrone, Fabiana
    Puntoni, Matteo
    Maglietta, Giuseppe
    Bordi, Paola
    Bria, Emilio
    Vita, Emanuele
    Gelsomino, Francesco
    De Giglio, Andrea
    Gelibter, Alain
    Siringo, Marco
    Mazzoni, Francesca
    Caliman, Enrico
    Genova, Carlo
    Bertolini, Federica
    Guaitoli, Giorgia
    Passiglia, Francesco
    Delcuratolo, Marco Donatello
    Montrone, Michele
    Cerea, Giulio
    Pasello, Giulia
    Roca, Elisa
    Belluomini, Lorenzo
    Cecere, Fabiana Letizia
    Guida, Annalisa
    Manzo, Anna
    Adamo, Vincenzo
    Rastelli, Francesca
    Bulotta, Alessandra
    Citarella, Fabrizio
    Toschi, Luca
    Zoratto, Federica
    Cortinovis, Diego Luigi
    Berardi, Rossana
    Follador, Alessandro
    Carta, Annamaria
    Camerini, Andrea
    Salerno, Flavio
    Silva, Rosa Rita
    Baldini, Editta
    Cortellini, Alessio
    Brighenti, Matteo
    Santoni, Matteo
    Malorgio, Francesco
    Caminiti, Caterina
    Tiseo, Marcello
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 202
  • [23] Real-World Patterns of First-Line Hydroxyurea Treatment Among Patients with Essential Thrombocythemia in US Community Oncology Practices
    Yu, Jingbo
    Colucci, Philomena
    Paranagama, Dilan Chamikara
    Sivaraman, Smitha
    Atanasov, Pavel
    Hanna, Becky
    Tang, Jackson
    Parasuraman, Shreekant V.
    [J]. BLOOD, 2017, 130
  • [24] Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
    King, Gentry
    Ittershagen, Stacie
    He, Luyang
    Shen, Ying
    Li, Frank
    Villacorta, Reginald
    [J]. ADVANCES IN THERAPY, 2022, 39 (12) : 5433 - 5452
  • [25] Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
    Gentry King
    Stacie Ittershagen
    Luyang He
    Ying Shen
    Frank Li
    Reginald Villacorta
    [J]. Advances in Therapy, 2022, 39 : 5433 - 5452
  • [26] Real-world evidence of first-line pembrolizumab plus chemotherapy in metastatic non-squamous NSCLC: A single-centre experience
    Bose, Subhadeep
    Khaja, Mujtaba Syed
    Siva, Asha
    Wilson, Paula
    Grist, Helen
    Murukesh, Nishanth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] First-line pembrolizumab monotherapy for metastatic PD-L1-positive NSCLC: real-world analysis of time on treatment
    Velcheti, Vamsidhar
    Chandwani, Sheenu
    Chen, Xin
    Pietanza, M. Catherine
    Burke, Thomas
    [J]. IMMUNOTHERAPY, 2019, 11 (10) : 889 - 901
  • [28] Clinical outcomes for advanced thymoma patients receiving platinum-based chemotherapy as first-line treatment
    Hao, Y.
    Sun, W.
    Zeng, X.
    Shi, Z.
    Wang, W.
    Xu, C.
    Song, Z.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S157 - S157
  • [29] Real-world treatment patterns and outcomes among patients with BRAF plus metastatic melanoma refractory to first-line immunotherapy
    Truong, T. G.
    Chandra, S.
    Connolly, L.
    Shah, R.
    Byrne, C.
    Tang, J.
    Eroglu, Z.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S673 - S673
  • [30] Treatment Patterns and Outcomes of First-line Osimertinib-treated Advanced EGFR Mutated NSCLC Patients: A Real-world Study
    Lee, J. Y.
    Mai, V.
    Garcia, M.
    Cheng, S.
    Khan, K.
    Balaratnam, K.
    Thakral, A.
    Brown, M. C.
    Zhan, L.
    Corke, L.
    Leighl, N.
    Shepherd, F. A.
    Bradbury, P.
    Sacher, A.
    Liu, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S440 - S440
12345